Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance

Table 1

Characteristics of study subjects by disease status and data source.

		Caucasians, 𝑁 (%)		African Americans, 𝑁 (%)
		Cases, (𝑛=1232)	Controls, (𝑛=595)	Cases, (𝑛=60)	Controls, (𝑛=87)
Age^1	Mean ± SD	60.0±7.4	61.3±9.6	56.4±7.4	57.3±9.2
Gleason score	≤6	628 (60.6)	N/A	34 (60.6)	N/A
	7	348 (33.6)		19 (33.9)
	8–10	60 (5.8)		3 (5.3)
Stage	1	55 (4.5)	N/A	2 (3.4)	N/A
	2	955 (78.3)		48 (81.4)
	3	201 (16.5)		9 (15.2)
	4	9 (0.7)		0 (0.0)
PSA level		7.5±9.1	1.1±1.1	5.1±3.1	1.3±1.4
Recurrence	No	905 (73.6)	N/A	43 (71.7)	N/A
	Yes	325 (26.4)		17 (28.3)
Death	Alive	975 (79.9)		54 (90.0)
	PCa death	106 (8.7)		2 (3.3)
	Other death cases	139 (11.4)		4 (6.7)
Marital status	Divorced	80 (6.6)		5 (8.3)
	Married	1057 (87.0)		49 (81.7)
	Separated	4 (0.3)		1 (1.7)
	Widowed	21 (1.7)		0 (0)
	Single	53 (4.4)		5 (8.3)
Weight (kg)		88.4±14.6	93.6±21.6	90.5±14.2	92.5±18.7
Height (m)		1.76±0.07	1.76±0.18	1.77±0.06	1.75±0.21

1Age at diagnosis for cases and age at enrolment for controls.